Cost implications to health care payers of improving glucose management among adults with type 2 diabetes

Health Services Research

Volumn 46, Issue 4, 2011, Pages 1158-1179

  Nuckols, Teryl K ^a,b   McGlynn, Elizabeth A ^c   Adams, John ^b   Lai, Julie ^b   Go, Myong Hyun ^a   Keesey, Joan ^b   Aledort, Julia E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c KAISER PERMANENTE   (United States)

^d AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

cost and cost analysis; cost benefit analysis; diabetes mellitus; Quality of health care

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DIABETIC PATIENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSURANCE CLAIM REVIEW; MODELS, ECONOMIC; PATIENT COMPLIANCE; QUALITY OF HEALTH CARE;

EID: 79960081463     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2011.01257.x     Document Type: Article

References (57)

1. Alexander, G. C., N. L. Sehgal, R. M. Moloney, and, R. S. Stafford,. 2008. " National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007. Archives of Internal Medicine 168 (19): 2088-94.
2. American Diabetes Association (ADA). 2008a. " Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care 31 (3): 596-615.
3. American Diabetes Association (ADA). 2008b. " Standards of Medical Care in Diabetes- 2008. Diabetes Care 31 (suppl 1): S12-54.
4. American Diabetes Association (ADA). 2010. " Standards of Medical Care in Diabetes- 2010. Diabetes Care 33: S11-61.
5. Aron, D., and, L. Pogach,. 2008. " Quality Indicators for Diabetes Mellitus in the Ambulatory Setting: Using the Delphi Method to Inform Performance Measurement Development. Quality & Safety in Health Care 17: 315-7.
6. Austvoll-Dahlgren, A., M. Aaserud, G. Vist, C. Ramsay, A. D. Oxman, H. Sturm, J. P. Kösters, and, A. Vernby,. 2008. " Pharmaceutical Policies: Effects of Cap and Co-Payment on Rational Drug Use. Cochrane Database of Systemic Reviews 23 (1): CD007017.
7. Balkrishnan, R., R. Rajagopalan, F. T. Camacho, S. A. Huston, F. T. Murray, and, R. T. Anderson,. 2003. " Predictors of Medication Adherence and Associated Health Care Costs in an Older Population with Type 2 Diabetes Mellitus: A Longitudinal Cohort Study. Clinical Therapeutics 25 (11): 2958-71. (Pubitemid 37510603)
8. Berlowitz, D. R., A. S. Ash, M. Glickman, R. H. Friedman, L. M. Pogach, A. L. Nelson, and, A. T. Wong,. 2005. " Developing a Quality Measure for Clinical Inertia in Diabetes Care. Health Services Research 40 (6, Part 1): 1836-53. (Pubitemid 41814237)
9. Bodmer, M., C. Meier, S. Krahenbuhl, S. S. Jick, and, C. Meir,. 2008. " Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A Nested Case-Control Analysis. Diabetes Care 31 (11): 2086-91.
10. Bolen, S., L. Feldman, J. Vassy, L. Wilson, H. C. Yeh, S. Marinopoulos, C. Wiley, E. Selvin, R. Wilson, E. B. Bass, and, F. L. Brancati,. 2007. " Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus. Annals of Internal Medicine 147 (6): 386-99.
11. Brook, R. H., E. A. McGlynn, and, P. D. Cleary,. 1996. " Quality of Health Care. Part 2: Measuring Quality of Care. The New England Journal of Medicine 335 (13): 966-70.
12. Brown, J. B., G. A. Nichols, H. S. Glauber, and, A. W. Bakst,. 1999. " Type 2 Diabetes: Incremental Medical Care Costs during the First 8 Years after Diagnosis. Diabetes Care 22 (7): 1116-24.
13. Caro, J. J., A. J. Ward, and, J. A. O'Brien,. 2002. " Lifetime Costs of Complications Resulting from Type 2 Diabetes in the U.S. Diabetes Care 25 (3): 476-81. (Pubitemid 41103339)
14. CDC Diabetes Cost-effectiveness Group. 2002. " Cost-Effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes. Journal of the American Medical Association 287 (19): 2542-51.
15. Chen, J. Y., H. Tian, D. Taira Juarez, K. A. Hodges, J. C. Jr. Brand, R. S. Chung, and, A. P. Legorreta,. 2010. " The Effect of a PPO Pay-for-Performance Program on Patients with Diabetes. The American Journal of Managed Care 16 (1): e11-9.
16. Clarke, P., A. Gray, A. Adler, R. Stevens, M. Raikou, C. Cull, I. Stratton, R. Holman, United Kingdom Prospective Diabetes Study (UKPDS) Group. 2001. " Cost-Effectiveness Analysis of Intensive Blood-Glucose Control with Metformin in Overweight Patients with Type II Diabetes (UKPDS No. 51). Diabetologia 44 (3): 298-304. (Pubitemid 32234454)
17. Clarke, P. M., A. M. Gray, A. Briggs, R. J. Stevens, D. R. Matthews, R. R. Holman, UKPDS 72 United Kingdom Prospective Diabetes Study. 2005. " Cost-Utility Analyses of Intensive Blood Glucose and Tight Blood Pressure Control in Type 2 Diabetes (UKPDS 72). Diabetologia 48 (5): 868-77. (Pubitemid 40767979)
18. Cramer, J. A., 2004. " A Systematic Review of Adherence with Medications for Diabetes. Diabetes Care 27: 1218-24. (Pubitemid 38579798)
19. Cunningham, P. J., 2000. " Health Plan Switching: Choice or Circumstance? Health Affairs 19 (3): 158-64.
20. Currency Converter for 164 Currencies [database online]. 2008. [accessed on December 11, 2008]. Available at http://www.oanda.com/convert/classic
21. The Diabetes Control and Complications Trial Research Group. 1996. " The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial. Diabetes 45 (10): 1289-98.
22. Duckworth, W., C. Abraira, T. Moritz, D. Reda, N. Emanuele, P. D. Reaven, F. J. Zieve, J. Marks, S. N. Davis, R. Hayward, S. R. Warren, S. Goldman, M. McCarren, M. E. Vitek, W. G. Henderson, and, G. D. Huang,. 2008. " Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. The New England Journal of Medicine 360: 129-39.
23. Eggleston, K. N., N. D. Shah, S. A. Smith, A. E. Wagie, A. R. Williams, J. H. Grossman, E. R. Berndt, K. H. Long, R. Banerjee, and, J. P. Newhouse,. 2009. " The Net Value of Health Care for Patients with Type 2 Diabetes, 1997 to 2005. Annals of Internal Medicine 151 (6): 386-93.
24. Gray, A., M. Raikou, A. McGuire, P. Fenn, R. Stevens, C. Cull, I. Stratton, A. Adler, R. Holman, and, R. Turner,. 2000. " Cost Effectiveness of an Intensive Blood Glucose Control Policy in Patients with Type 2 Diabetes: Economic Analysis Alongside Randomised Controlled Trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. British Medical Journal 320 (7246): 1373-8.
25. Gray, A. M., and, P. Clarke,. 2008. " The Economic Analyses of the UK Prospective Diabetes Study. Diabetic Medicine 25 (suppl 2): 47-51. (Pubitemid 352020098)
26. Hoerger, T. J., J. E. Segel, E. W. Gregg, and, J. B. Saaddine,. 2008. " Is Glycemic Control Improving in U.S. Adults? Diabetes Care 31 (1): 81-6.
27. Holman, R. R., S. K. Paul, M. A. Bethel, D. R. Matthews, and, H. A. Neil,. 2008. " 10-Year Follow-Up of Intensive Glucose Control in Type 2 Diabetes. The New England Journal of Medicine 359 (15): 1577-89.
28. Huang, E. S., Q. Zhang, S. E. Brown, M. L. Drum, D. O. Meltzer, and, M. H. Chin,. 2007. " The Cost-Effectiveness of Improving Diabetes Care in U.S. Federally Qualified Community Health Centers. Health Services Research 42 (6, Part 1): 2174-93; discussion 294-323. (Pubitemid 350077336)
29. Kahn, R., R. M. Robertson, R. Smith, and, D. Eddy,. 2008. " The Impact of Prevention on Reducing the Burden of Cardiovascular Disease. Diabetes Care 31 (8): 1686-96.
30. Karter, A. J., M. M. Parker, H. H. Moffet, A. T. Ahmed, A. Ferrara, J. Y. Liu, and, J. V. Selby,. 2004. " Missed Appointments and Poor Glycemic Control: An Opportunity to Identify High-Risk Diabetic Patients. Medical Care 42 (2): 110-5.
31. Keers, J. C., H. Groen, W. J. Sluiter, J. Bouma, and, T. P. Links,. 2005. " Cost and Benefits of a Multidisciplinary Intensive Diabetes Education Programme. Journal of Evaluation in Clinical Practice 11 (3): 293-303. (Pubitemid 40755689)
32. Kelly, T. N., L. A. Bazzano, V. A. Fonseca, T. K. Thethi, K. Reynolds, and, J. He,. 2009. " Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes. Annals of Internal Medicine 151 (6): 394-403.
33. Kerr, E. A., R. B. Gerzoff, S. L. Krein, J. V. Selby, J. D. Piette, J. D. Curb, W. H. Herman, D. G. Marrero, K. M. Narayan, M. M. Safford, T. Thompson, and, C. M. Mangione,. 2004. " Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study. Annals of Internal Medicine 141 (4): 272-81.
34. Kim, S., 2007. " Burden of Hospitalizations Primarily Due to Uncontrolled Diabetes: Implications of Inadequate Primary Health Care in the United States. Diabetes Care 30 (5): 1281-2.
35. Luce, B. R., 2005. " What will It Take to Make Cost-Effectiveness Analysis Acceptable in the United States? Medical Care 43 (7, suppl): 44-8.
36. Martirosyan, L., J. Braspenning, P. Denig, W. J. de Grauw, M. Bouma, F. Storms, and, F. M. Haaijer-Ruskamp,. 2008. " Prescribing Quality Indicators of Type 2 Diabetes Mellitus Ambulatory Care. Quality & Safety in Health Care 17 (5): 318-23.
37. McDonald, R., and, M. Roland,. 2009. " Pay for Performance in Primary Care in England and California: Comparison of Unintended Consequences. Annals of Family Medicine 7 (2): 121-7.
38. McGlynn, E. A., S. M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, and, E. A. Kerr,. 2003. " The Quality of Health Care Delivered to Adults in the United States. The New England Journal of Medicine 348 (26): 2635-45. (Pubitemid 36741592)
39. Medicare Clinical Laboratory Fee Schedule [database online]. 2009. "Centers for Medicare and Medicaid Services" [accessed on May 7, 2009]. Available at http://www.cms.hhs.gov/ClinicalLabFeeSched/02-clinlab.as p#TopOfPage
40. Medicare Physician Fee Schedule Look-Up [database online]. 2009. "Centers for Medicare and Medicaid Services" [accessed on May 7, 2009]. Available at http://www.cms.hhs.gov/PFSlookup
41. Minshall, M. E., S. Roze, A. J. Palmer, W. J. Valentine, V. Foos, J. Ray, and, C. Graham,. 2005. " Treating Diabetes to Accepted Standards of Care: A 10-year Projection of the Estimated Economic and Health Impact in Patients with Type 1 and Type 2 Diabetes Mellitus in the United States." 27 (6): 940-50.
42. National Committee for Quality Assurance. 2008. "HEDIS 2009 Volume 2 Technical Update" [accessed on October 1, 2008]. Available at http://www.ncqa.org/tabid/784/Default.aspx
43. Rodondi, N., T. Peng, A. J. Karter, D. C. Bauer, E. Vittinghoff, S. Tang, D. Pettitt, E. A. Kerr, and, J. V. Selby,. 2006. " Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. Annals of Internal Medicine 144 (7): 475-84. (Pubitemid 46780670)
44. Rossi, M. C., M. Comaschi, A. Ceriello, C. Coscelli, D. Cucinotta, S. De Cosmo, P. Di Blasi, C. Giorda, I. Otranto, F. Pellegrini, B. Pomili, U. Valentini, G. Vespasiani, and, A. Nicolucci,. 2008. Correlation between Structure Characteristics, Process Indicators and Intermediate Outcomes in DM2: the QUASAR (Quality Assessment Score and Cardiovascular Outcomes in Italian Diabetic Patients) Study (Abstract). 68th Annual American Diabetes Association Annual Meeting, San Francisco, CA
45. Rothman, R. L., S. A. So, J. Shin, R. M. Malone, B. Bryant, D. A. Dewalt, M. P. Pignone, and, R. S. Dittus,. 2006. " Labor Characteristics and Program Costs of a Successful Diabetes Disease Management Program. The American Journal of Managed Care 12 (5): 277-83.
46. Rubin, R. R., 2005. " Adherence to Pharmacologic Therapy in Patients with Type 2 Diabetes Mellitus. The American Journal of Medicine 118 (suppl 5A): 27S-34. (Pubitemid 40585813)
47. Saaddine, J. B., B. Cadwell, E. W. Gregg, M. M. Engelgau, F. Vinicor, G. Imperatore, and, K. M. Narayan,. 2006. " Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002. Annals of Internal Medicine 144 (7): 465-74. (Pubitemid 46780669)
48. Saaddine, J. B., M. M. Engelgau, G. L. Beckles, E. W. Gregg, T. J. Thompson, and, K. M. Narayan,. 2002. " A Diabetes Report Card for the United States: Quality of Care in the 1990s. Annals of Internal Medicine 136 (8): 565-74.
49. Schmittdiel, J. A., C. S. Uratsu, A. J. Karter, M. Heisler, U. Subramanian, C. M. Mangione, and, J. V. Selby,. 2008. " Why Don't Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification. Journal of General Internal Medicine 23 (5): 588-94.
50. Shojania, K. G., S. R. Ranji, K. M. McDonald, J. M. Grimshaw, V. Sundaram, R. J. Rushakoff, and, D. K. Owens,. 2006. " Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control: A Meta-Regression Analysis. Journal of the American Medical Association 296 (4): 427-40. (Pubitemid 44127527)
51. Sidorov, J., R. Shull, J. Tomcavage, S. Girolami, N. Lawton, and, R. Harris,. 2002. " Does Diabetes Disease Management Save Money and Improve Outcomes? A Report of Simultaneous Short-Term Savings and Quality Improvement Associated with a Health Maintenance Organization-Sponsored Disease Management Program among Patients Fulfilling Health Employer Data and Information Set Criteria. Diabetes Care 25 (4): 684-9. (Pubitemid 41071187)
52. Sokol, M. C., K. A. McGuigan, R. R. Verbrugge, and, R. S. Epstein,. 2005. " Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care 43 (6): 521-30. (Pubitemid 40847288)
53. Stokey, E., and, R. Zeckhauser,. 1978. A Primer for Policy Analysis. New York: WW Norton and Company Inc.
54. UK Prospective Diabetes Study (UKPDS) Group. 1998. " Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet 352 (9131): 837-53.
55. U.S. Department of Labor: Bureau of Labor Statistics. 2007. "Consumer price index, all urban consumers, 1997-2007."
56. Wagner, E. H., N. Sandhu, K. M. Newton, D. K. McCulloch, S. D. Ramsey, and, L. C. Grothaus,. 2001. " Effect of Improved Glycemic Control on Health Care Costs and Utilization. Journal of the American Medical Association 285 (2): 182-9. (Pubitemid 32048520)
57. Wang, J., K. Imai, M. M. Engelgau, L. S. Geiss, C. Wen, and, P. Zhang,. 2009. " Secular Trends in Diabetes-Related Preventable Hospitalizations in the United States, 1998-2006. Diabetes Care 32 (7): 1213-7.